$50M+ in Identified Opportunities through Data-Driven Insights
The unique ability to quickly see outcomes and associations across long spans of time and within large datasets and patient populations helps the team establish clear trends and discern new, authoritative insights. Fast generation of data-driven insights combined with a user’s clinical knowledge results in more insightful queries and a more accessible and repeatable research process.
The early success of Intermountain’s chronic kidney disease (CKD) program has led to other initiatives targeting coronary artery disease, diabetes, hyperlipidemia, and opioids in surgery, all of which are paying significant dividends. Intermountain has closed gaps in cardiovascular care, resulting in reductions of cardiac events, creating savings in excess of $7M annually. They have also seen a 10% increase in newly diagnosed diabetes patients transitioning to more physically active lifestyles, saving another estimated $21.6M annually.
READ THE full CASE STUDY →
-
Seventy percent of late-stage renal disease patients at Intermountain Healthcare were “crashing” into dialysis unaware of their disease – a worst-case scenario for both patients and the bottom line. Intermountain set out to reduce hospitalizations and prevent unnecessary morbidity and mortality by identifying and engaging patients in early stages of CKD.
-
With results of its patient population in hand, Intermountain will be able to define an action plan for its business and change how it makes care available to patients across all diabetes care locations. This will help patients become more compliant with their care plans, prescriptions, and follow-up visits.
-
Because high cholesterol has no direct symptoms, many patients are unaware they carry this major risk factor for cardiovascular disease.
Undiagnosed and untreated, these patients represent an enormous potential future burden to the health system. There are several modifiable risk factors for CVD, including overweight and obesity, lack of exercise, smoking, excessive alcohol consumption, and an unhealthy diet. The discovery of the cholesterol-lowering drugs, statins, has resulted in a marked improvement in mean cholesterol levels among U.S. adults over the past 20 years. Timely diagnosis of dyslipidemia followed by prompt risk-factor modification and, when appropriate, initiation of pharmacological treatment, can directly improve population health and lower the cost of care.
-
The Intermountain team has been able to provide evidence based therapy for every day patient care, including a trusted probability of adverse events by risk factors, by leveraging community based data previously locked away in unstructured text.
-
A team at Intermountain Healthcare performed an analysis of standard of care compared with national benchmarks in outcomes regarding pulmonary embolism response for its tertiary care centers. The care team based evaluated outcomes based on current literature as well as variability in cost of episode of care by facility and treatment path. This opened visibility to a state of care that had never previously been realized with data at Intermountain.
Viet Le, MPAS, PA-C, FACC, FAHA, Associate Professor of Research/Cardiology Research, Intermountain Healthcare
Peter Calderone, Director, Clinical and Data Science, Customer Success, MDClone
Intermountain Healthcare Significantly Enhances Care for Chronic Kidney Disease Patients in Early Identification and Engagement
READ THE PRESS RELEASE →
Intermountain Focuses on Early Identification of Kidney Disease Patients
READ THE PRESS RELEASE →
Intermountain Healthcare Joins The Global Network
READ THE PRESS RELEASE →
Launching a Data-Focused Collaboration
read the announcement →
MORE NEWS & PRESS →
Join 2,000+ healthcare professionals on the newsletter list.
Insights from MDClone
